Suppr超能文献

全州范围内减少无症状菌尿不必要抗生素治疗的质量倡议。

A Statewide Quality Initiative to Reduce Unnecessary Antibiotic Treatment of Asymptomatic Bacteriuria.

机构信息

Division of General Internal Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City.

Division of Health System Innovation & Research, Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City.

出版信息

JAMA Intern Med. 2023 Sep 1;183(9):933-941. doi: 10.1001/jamainternmed.2023.2749.

Abstract

IMPORTANCE

Hospitalized patients with asymptomatic bacteriuria (ASB) often receive unnecessary antibiotic treatment, which increases antibiotic resistance and adverse events.

OBJECTIVE

To determine whether diagnostic stewardship (avoiding unnecessary urine cultures) or antibiotic stewardship (reducing unnecessary antibiotic treatment after an unnecessary culture) is associated with better outcomes in reducing antibiotic use for ASB.

DESIGN, SETTING, AND PARTICIPANTS: This 3-year, prospective quality improvement study included hospitalized general care medicine patients with a positive urine culture among 46 hospitals participating in a collaborative quality initiative, the Michigan Hospital Medicine Safety Consortium. Data were collected from July 1, 2017, through March 31, 2020, and analyzed from February to October 2022.

EXPOSURE

Participation in the Michigan Hospital Medicine Safety Consortium with antibiotic and diagnostic stewardship strategies at hospital discretion.

MAIN OUTCOMES AND MEASURES

Overall improvement in ASB-related antibiotic use was estimated as change in percentage of patients treated with antibiotics who had ASB. Effect of diagnostic stewardship was estimated as change in percentage of patients with a positive urine culture who had ASB. Effect of antibiotic stewardship was estimated as change in percentage of patients with ASB who received antibiotics and antibiotic duration.

RESULTS

Of the 14 572 patients with a positive urine culture included in the study (median [IQR] age, 75.8 [64.2-85.1] years; 70.5% female); 28.4% (n = 4134) had ASB, of whom 76.8% (n = 3175) received antibiotics. Over the study period, the percentage of patients treated with antibiotics who had ASB (overall ASB-related antibiotic use) declined from 29.1% (95% CI, 26.2%-32.2%) to 17.1% (95% CI, 14.3%-20.2%) (adjusted odds ratio [aOR], 0.94 per quarter; 95% CI, 0.92-0.96). The percentage of patients with a positive urine culture who had ASB (diagnostic stewardship metric) declined from 34.1% (95% CI, 31.0%-37.3%) to 22.5% (95% CI, 19.7%-25.6%) (aOR, 0.95 per quarter; 95% CI, 0.93-0.97). The percentage of patients with ASB who received antibiotics (antibiotic stewardship metric) remained stable, from 82.0% (95% CI, 77.7%-85.6%) to 76.3% (95% CI, 68.5%-82.6%) (aOR, 0.97 per quarter; 95% CI, 0.94-1.01), as did adjusted mean antibiotic duration, from 6.38 (95% CI, 6.00-6.78) days to 5.93 (95% CI, 5.54-6.35) days (adjusted incidence rate ratio, 0.99 per quarter; 95% CI, 0.99-1.00).

CONCLUSIONS AND RELEVANCE

This quality improvement study showed that over 3 years, ASB-related antibiotic use decreased and was associated with a decline in unnecessary urine cultures. Hospitals should prioritize reducing unnecessary urine cultures (ie, diagnostic stewardship) to reduce antibiotic treatment related to ASB.

摘要

重要性

患有无症状菌尿症 (ASB) 的住院患者经常接受不必要的抗生素治疗,这会增加抗生素耐药性和不良事件的发生。

目的

确定诊断管理(避免不必要的尿液培养)或抗生素管理(在不必要的培养后减少不必要的抗生素治疗)是否与减少 ASB 抗生素使用的更好结果相关。

设计、设置和参与者:这是一项为期 3 年的前瞻性质量改进研究,包括在参与协作质量倡议密歇根医院医学安全联盟的 46 家医院中,患有阳性尿液培养的住院普通内科患者。数据于 2017 年 7 月 1 日至 2020 年 3 月 31 日采集,并于 2022 年 2 月至 10 月进行分析。

暴露

在医院自行决定的情况下参与密歇根医院医学安全联盟的抗生素和诊断管理策略。

主要结果和措施

总体上,ASB 相关抗生素使用的改善情况估计为接受抗生素治疗的患者中有 ASB 的百分比变化。诊断管理的效果估计为阳性尿液培养患者中有 ASB 的百分比变化。抗生素管理的效果估计为 ASB 患者接受抗生素治疗和抗生素持续时间的百分比变化。

结果

在包括的 14572 名阳性尿液培养患者中(中位数[IQR]年龄,75.8 [64.2-85.1] 岁;70.5%女性);28.4%(n=4134)患有 ASB,其中 76.8%(n=3175)接受了抗生素治疗。在研究期间,接受抗生素治疗的患者中有 ASB 的百分比(总体 ASB 相关抗生素使用)从 29.1%(95%CI,26.2%-32.2%)下降到 17.1%(95%CI,14.3%-20.2%)(调整后的优势比[OR],每季度 0.94;95%CI,0.92-0.96)。有阳性尿液培养的患者中有 ASB 的百分比(诊断管理指标)从 34.1%(95%CI,31.0%-37.3%)下降到 22.5%(95%CI,19.7%-25.6%)(调整后的 OR,每季度 0.95;95%CI,0.93-0.97)。接受抗生素治疗的 ASB 患者的百分比(抗生素管理指标)保持稳定,从 82.0%(95%CI,77.7%-85.6%)降至 76.3%(95%CI,68.5%-82.6%)(调整后的 OR,每季度 0.97;95%CI,0.94-1.01),调整后的平均抗生素持续时间也保持稳定,从 6.38 天(95%CI,6.00-6.78 天)降至 5.93 天(95%CI,5.54-6.35 天)(调整后的发病率比,每季度 0.99;95%CI,0.99-1.00)。

结论和相关性

这项质量改进研究表明,在 3 年期间,ASB 相关抗生素使用减少,并与不必要的尿液培养减少相关。医院应优先减少不必要的尿液培养(即诊断管理),以减少与 ASB 相关的抗生素治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c57/10334295/b1d7f7b55fa7/jamainternmed-e232749-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验